← Back to Search

Peer + Text Message Support for Mental Illness

N/A

Waitlist Available

Led By Vincent Agyapong, MD,PhD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who are 18 or 65 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 24 weeks, 52 weeks

Awards & highlights

Study Summary

This trial will test whether sending supportive text messages to patients' mobile phones can reduce psychiatric readmissions and emergency department visits.

Who is the study for?

This trial is for adults aged 18 to 65 who are being discharged from acute psychiatric care, have a mental health diagnosis, can consent to participate, and own a mobile device that can receive texts. It's not for those with addiction disorders without a mental health diagnosis or who cannot read texts.Check my eligibility

What is being tested?

The study tests whether daily supportive text messages based on cognitive behavioral therapy principles and peer support by recovered patients can reduce hospital readmissions among recently discharged psychiatric patients awaiting follow-up treatment.See study design

What are the potential side effects?

There may be no direct medical side effects from participating in this trial as it involves receiving text messages and peer support rather than medication. However, participants might experience emotional discomfort or distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 24 weeks, 52 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 24 weeks, 52 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 24 weeks, 52 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in 30 day readmission rate

Secondary outcome measures

Change in Brief Resilience Scale scores

Change in Clinical Outcomes in Routine Evaluation 10 (CORE-10) scores

Change in EuroQol- 5 Dimension (EQ-5D)scores

+2 more

Other outcome measures

Acceptability of the intervention

Change in the Reach of the Text4Support

Change in the fidelity of the intervention

+1 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Text message with or without peer supportExperimental Treatment2 Interventions

All individuals in this cluster will receive daily text message support for six months plus weekly text message over 6 weeks (six information text messages all together) with some selected members also receiving peer support for six months

Group II: Text Message clusterExperimental Treatment1 Intervention

This arm will receive only daily text message support for six months plus weekly text message over 6 weeks (six information text messages all together)

Group III: Control groupActive Control1 Intervention

This group will only receive usual care plus weekly text message over 6 weeks (six information text messages all together) with provides information about community services

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

383,646 Total Patients Enrolled

Alberta Innovates Health SolutionsOTHER

52 Previous Clinical Trials

93,113 Total Patients Enrolled

Vincent Agyapong, MD,PhDPrincipal InvestigatorUniversity of Alberta

1 Previous Clinical Trials

66 Total Patients Enrolled

Media Library

Text Message cluster Clinical Trial Eligibility Overview. Trial Name: NCT05133726 — N/A

Mental Illness Research Study Groups: Text Message cluster, Text message with or without peer support, Control group

Mental Illness Clinical Trial 2023: Text Message cluster Highlights & Side Effects. Trial Name: NCT05133726 — N/A

Text Message cluster 2023 Treatment Timeline for Medical Study. Trial Name: NCT05133726 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment enrolling individuals aged over 35?

"This research is searching for qualified participants aged 18 to 65."

Answered by AI

Is there an opportunity to join this medical experiment?

"To qualify for admittance to this clinical study, participants must possess a mental illness and fall between the ages of 18 and 65. The team is targeting 10800 patients in total."

Answered by AI

How many participants has this medical trial attracted thus far?

"Yes, according to the information found on clinicaltrials.gov, this trial is still open for enrollment. It was first posted on March 1st 2022 and most recently updated April 3rd of that same year- seeking a total of 10800 participants from 7 sites."

Answered by AI

Are investigators currently signing up participants for this research experiment?

"Affirmative. Evidence on clinicaltrials.gov indicates that enrollment is still open for this trial, which was first posted March 1st 2022 and subsequently amended April 3rd 2022. To date it has taken in 10800 individuals from 7 different medical facilities."

Answered by AI